Page 1 of 1

Nutra Pharma receives patent for their MS drug

Posted: Wed Oct 19, 2011 5:45 am
by MSUK
Image

Nutra Pharma Corporation, a biotechnology company that is developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV/AIDS), Adrenomyeloneuropathy (AMN) and Pain, announced today that its wholly-owned subsidiary, ReceptoPharm, has received approval from the United States Patent and Trademark Office (USPTO) for its patent describing the composition of matter and the use of neurotoxins for the treatment of Multiple Sclerosis (MS).

"This is the third patent to be issued to our ReceptoPharm subsidiary in the last 16 months," commented Rik J Deitsch, Chairman and CEO of Nutra Pharma Corporation. "These patents are key to the continuing development of our pipeline and provide the value for eventual commercialization of the technology or out-licensing of the drugs. We currently own or license twelve patents that protect a broad range of drug and medical device technologies," he explained.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1849